Saierxin Bio

赛尔欣生物

Saierxin Bio

Other

Saierxin Bio has long focused on the development of Treg cell therapy drugs. With a fully proprietary, independently innovative Treg pipeline, an experienced management (or partnership) team, and multiple key R&D projects advancing rapidly, the company has become a significant force in Treg drug…

Latest round: Pre Series A Extension (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-21